H. Ralph Snodgrass

2019

In 2019, H. Ralph Snodgrass earned a total compensation of $642.3K as President, Chief Scientific Officer at Vistagen Therapeutics.

Compensation breakdown

Bonus$73,444
Option Awards$174,823
Salary$393,991
Total$642,258

Snodgrass received $394K in salary, accounting for 61% of the total pay in 2019.

Snodgrass also received $73.4K in bonus and $174.8K in option awards.

Rankings

In 2019, H. Ralph Snodgrass' compensation ranked 10,995th out of 13,971 executives tracked by ExecPay. In other words, Snodgrass earned more than 21.3% of executives.

ClassificationRankingPercentile
All
10,995
out of 13,971
21st
Division
Manufacturing
4,450
out of 5,695
22nd
Major group
Chemicals And Allied Products
1,738
out of 2,194
21st
Industry group
Drugs
1,492
out of 1,880
21st
Industry
Pharmaceutical Preparations
1,103
out of 1,392
21st
Source: SEC filing on July 27, 2020.

Snodgrass' colleagues

We found four more compensation records of executives who worked with H. Ralph Snodgrass at Vistagen Therapeutics in 2019.

2019

Shawn Singh

Vistagen Therapeutics

Chief Executive Officer

2019

Mark Smith

Vistagen Therapeutics

Chief Medical Officer

2019

Jerrold Dotson

Vistagen Therapeutics

Chief Financial Officer

2019

Mark McPartland

Vistagen Therapeutics

Vice President, Corporate Development

News

You may also like